|
Adrian Luchini, is one of St. Louis' most distinguished architects |
![]() |
|
||||
|
||||||||||||||||||||||||||||
|
Human Genome Project colloquia continue April 5
By Jessica N. Roberts Difficult ethical and policy questions will be addressed at "Research: Germ-Line Interventions and Human Research Ethics," the second of three Human Genome Project colloquia, April 5 in Anheuser-Busch Hall, Room 310. The colloquium, led by Rebecca Dresser, J.D., the Daniel Noyes Kirby Professor of Law and professor of ethics in medicine, is one of four components of the yearlong program "Law and the Human Genome Project: Research, Medicine, and Commerce," co-sponsored by the School of Law's Center for Interdisciplinary Studies and the School of Medicine. The topics to be explored and colloquium events are: ¥ 1-1:20 p.m.: Introduction by Dresser ¥ 1:20-2:10 p.m.: "Inheritable Genetic Modification and a Brave New World: Did Huxley Have It Wrong?" -- Mark Frankel, Ph.D., director of the Scientific Freedom, Responsibility and Law Program for the American Association for the Advancement of Science ¥ 2:10-3 p.m.: "Accident and Desire: Germ-Line Interventions and Effects in Clinical Research" -- Nancy M. P. King, J.D. professor in the Department of Social Medicine at University of North Carolina at Chapel Hill ¥ 3-3:20 p.m.: Break ¥ 3:20-3:50 p.m.: Comments: Pilar Ossorio, J.D., Ph.D., assistant professor of law and medical ethics and associate director of the Center for Study of Race and Ethnicity in Medicine at the University of Wisconsin at Madison ¥ 3:50-4:10 p.m.: Comments: Anne Bowcock, Ph.D., professor of genetics, pediatrics and medicine at Washington University; and Daniel B. Williams, M.D., associate professor of obstetrics and gynecology at Washington University ¥ 4:10-5:15 p.m.: Speakers' roundtable ¥ 5:15-6:15 p.m.: Reception
For more information about the colloquium, contact Linda McClain at 935-7988. The next colloquium, "Commerce: Patenting Genetic Products," will be held April 12-13.
|
||||||||||||||||||||||||||||
|